Targeting Multidrug-Resistant <italic toggle="yes">Acinetobacter</italic> spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent

Targeting Multidrug-Resistant <italic toggle="yes">Acinetobacter</italic> spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent

ABSTRACT Multidrug-resistant (MDR) Acinetobacter spp. poses a significant therapeutic challenge in part due to the presence of chromosomally encoded β-lactamases, including class C Acinetobacter-derived cephalosporinases (ADC) and class D oxacillinases (OXA), as well as plasmid-mediated class A β-la...

Full description

Saved in:
Bibliographic Details
Main Authors: Melissa D. Barnes, Vijay Kumar, Christopher R. Bethel, Samir H. Moussa, John O’Donnell, Joseph D. Rutter, Caryn E. Good, Kristine M. Hujer, Andrea M. Hujer, Steve H. Marshall, Barry N. Kreiswirth, Sandra S. Richter, Philip N. Rather, Michael R. Jacobs, Krisztina M. Papp-Wallace, Focco van den Akker, Robert A. Bonomo
Format: article
Language:EN
Published: American Society for Microbiology 2019
Subjects:
Acinetobacter
DBO
diazabicyclooctanone
diazabicyclooctenone
ETX2514
sulbactam
Microbiology
QR1-502
Online Access:https://doaj.org/article/e9fdc0602a7742b6a7a1c6dfc92d0ab3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/e9fdc0602a7742b6a7a1c6dfc92d0ab3

Similar Items